Imomed

Zopiclone, the active ingredient in Imomed, is a cyclopyrrolone presented as an oral tablet for oral administration. It is indicated for the short‑term management of insomnia, assisting adults who experience difficulty falling asleep or staying asleep, thereby improving sleep continuity and overall restfulness.

GNH USA supplies Imomed as a licensed, GDP‑compliant product, providing reliable access to hospitals, pharmacies and clinics worldwide under EU‑quality standards. The company ensures each batch meets stringent pharmacopoeial specifications and is shipped with appropriate documentation for international markets.

Zopiclone is a hypnotic agent used to treat sleep disorders.

- Insomnia (difficulty initiating sleep): helps patients fall asleep faster. - Insomnia (difficulty maintaining sleep): reduces nighttime awakenings. - Short‑term sleep disturbance: provides temporary relief of sleep difficulty.

Zopiclone may cause a range of adverse reactions.

Common Side Effects: - Drowsiness or fatigue. - Dry mouth. - Bitter or metallic taste. - Headache. - Dizziness. - Nausea or abdominal discomfort.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling. - Complex sleep behaviours (e.g., sleepwalking, sleep‑driving). - Memory impairment or amnesia. - Mood changes including depression or suicidal thoughts. - Respiratory depression, especially when combined with other depressants. - Severe hypotension.

Zopiclone should be used with caution and under medical supervision. - Assess sleep duration: limit use to short‑term periods as recommended by a clinician. - Evaluate concomitant CNS depressants: avoid combining with alcohol or other sedatives. - Monitor for abnormal behaviours: watch for sleepwalking or other complex activities. - Review renal or hepatic impairment: dose adjustment may be required. - Store at ambient temperature (below 25°C): keep in the original pack, protect from moisture.

Zopiclone can interact with several drug classes.

Major Interactions (Avoid): - Alcohol: may cause profound sedation and respiratory depression. - Opioids: additive central nervous system depression increasing risk of overdose. - Other CNS depressants (e.g., antihistamines, benzodiazepines): can lead to excessive sedation.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise plasma levels of Zopiclone. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce therapeutic effect. - Selective serotonin reuptake inhibitors (SSRIs): may increase risk of abnormal sleep behaviours.